Return to the home page of the Diabetes Monitor
Current Pharmaceutical Management of Diabetes
Advertisement



 
go to home page read about us contact us read our disclaimer go to the index read our mission statement read our privacy policy search our website go to the site map find out what's new

repaglinide (Prandin) (Continued)

  • Start with low dose (0.5-2.0 mg/meal); increase weekly PRN (Maximum recommended dose is 4 mg/meal, 16 mg/day)

  • Approved for monotherapy or with metformin

  • May cause hypoglycemia

  • Weight gain possible

Previous slide Next slide Back to first slide View graphic version

Advertisements




Google Ads


  [Top]  
Webpage new at the DiabetesMonitor 12June2000
 
Advertisement
 

Return to the home page of the Diabetes Monitor Go to the index Search this website Go to the site map Read our copyright noticeRead our copyright notice Send us an e-mail at info@diabetesmonitor.com